One small wearable. And zero fingersticks*. Learn why Medicare patients are using the Dexcom G6 Continuous Glucose Monitoring (CGM) System to manage diabetes. *If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. *For a list of compatible devices, visit dexcom.com/compatibility. Dexcom is a registered trademark of Dexcom, Inc. in the U.S., and may be registered in other countries. ©2020 Dexcom, Inc.

It’s easy to use, covered for Medicare patients* on mealtime insulin, and proven to lower A1C1,2. See why the Dexcom G6 Continuous Glucose Monitoring (CGM) System might be right for you. *Patients must meet coverage criteria. 1 Beck RW, et al. JAMA. 2017; 317(4); 371-378. 2 Welsh JB, et al. Diabetes Technol Ther. 2019; 21(3): 128-132. Dexcom is a registered trademark of Dexcom, Inc. in the U.S., and may be registered in other countries. ©2020 Dexcom, Inc. All rights reserved. | Dexcom